Artiva Biotherapeutics Statistics

Total Valuation

ARTV has a market cap or net worth of $91.57 million. The enterprise value is -$40.09 million.

Market Cap	91.57M
Enterprise Value	-40.09M

Important Dates

The next estimated earnings date is Tuesday, March 4, 2025, before market open.

Earnings Date	Mar 4, 2025
Ex-Dividend Date	n/a

Share Statistics

ARTV has 24.29 million shares outstanding. The number of shares has increased by 589.85% in one year.

Current Share Class	24.29M
Shares Outstanding	24.29M
Shares Change (YoY)	+589.85%
Shares Change (QoQ)	+2,229.46%
Owned by Insiders (%)	0.26%
Owned by Institutions (%)	23.52%
Float	4.32M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	7.78
Forward PS	n/a
PB Ratio	0.46
P/TBV Ratio	0.46
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 11.33, with a Debt / Equity ratio of 0.07.

Current Ratio	11.33
Quick Ratio	11.14
Debt / Equity	0.07
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	n/a
Return on Capital Employed (ROCE)	-28.73%
Revenue Per Employee	$60,488
Profits Per Employee	-$1.43M
Employee Count	43
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, ARTV has paid $72,000 in taxes.

Income Tax	72,000
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	7.62
200-Day Moving Average	n/a
Relative Strength Index (RSI)	27.56
Average Volume (20 Days)	83,115

Short Selling Information

The latest short interest is 1.17 million, so 4.81% of the outstanding shares have been sold short.

Short Interest	1.17M
Short Previous Month	1.25M
Short % of Shares Out	4.81%
Short % of Float	27.01%
Short Ratio (days to cover)	15.66

Income Statement

In the last 12 months, ARTV had revenue of $2.60 million and -$61.28 million in losses. Loss per share was -$11.42.

Revenue	2.60M
Gross Profit	2.60M
Operating Income	-60.99M
Pretax Income	n/a
Net Income	-61.28M
EBITDA	-58.57M
EBIT	-60.99M
Loss Per Share	-$11.42

Full Income Statement

Balance Sheet

The company has $146.63 million in cash and $14.97 million in debt, giving a net cash position of $131.66 million or $5.42 per share.

Cash & Cash Equivalents	146.63M
Total Debt	14.97M
Net Cash	131.66M
Net Cash Per Share	$5.42
Equity (Book Value)	201.00M
Book Value Per Share	8.28
Working Capital	137.27M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$51.06 million and capital expenditures -$1.21 million, giving a free cash flow of -$52.27 million.

Operating Cash Flow	-51.06M
Capital Expenditures	-1.21M
Free Cash Flow	-52.27M
FCF Per Share	-$2.15

Full Cash Flow Statement

Margins

Gross Margin	100.00%
Operating Margin	-2,344.68%
Pretax Margin	-2,353.09%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

ARTV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-589.85%
Shareholder Yield	-589.85%
Earnings Yield	-66.92%
FCF Yield	-57.08%

Analyst Forecast

The average price target for ARTV is $21.00, which is 457.03% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$21.00
Price Target Difference	457.03%
Analyst Consensus	Strong Buy
Analyst Count	6
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ARTV has an Altman Z-Score of 4.83 and a Piotroski F-Score of 1.

Altman Z-Score	4.83
Piotroski F-Score	1